Work

Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-125396

Authors: Y. Lynn Lynn Wang, Carrie Franzen, Shengchun Wang, Girish Venkataraman, Lei Li, Nifang Niu, Madina Sukhanova, Yifan Tu, Juehua Gao, Yi-Hua Chen, Shuo Ma, Richard A. Larson, Lu Pin

Institutions: Fox Chase Cancer Center, University of Chicago, Guangdong Medical College, Northwestern University, Saint Louis University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990234276

Cites:

Cited by: 3

Related to: 10